Gelion PLC (GB:GELN)
LSE:GELN
GELN Stock Chart & Stats
18.50 p
1.00 p(6.25%)
At close: 4:00 PM EST
18.50 p
1.00 p(6.25%)
Day’s Range― - ―
52-Week Range9.20 p - 30.00 p
Previous CloseN/A
Volume5.00K
Average Volume (3M)395.75K
Market Cap
£30.97M
Enterprise Value13.41M
Total Cash (Recent Filing)£10.52M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta-0.06
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding229,421,460
10 Day Avg. Volume121,404
30 Day Avg. Volume395,753
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)3.53
Price to Sales (P/S)38.63
P/FCF Ratio-7.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Balance Sheet StrengthGelion's extremely low net leverage materially reduces near-term solvency risk and gives management flexibility to prioritise grant capture and targeted capex over debt servicing. This balance-sheet conservatism preserves runway and strategic optionality during commercialization.
Partnerships & Technical MilestonesSuccessful pouch-cell prototyping with TDK and Gen‑3 cell builds via QinetiQ, alongside achieved CAM scale targets, indicate core chemistry and early-scale manufacturing are progressing. Strong technical validation with established partners reduces execution risk and aids customer credibility.
Non‑dilutive Funding & Improved EBITDAExtension of ARENA funding and capture of grants, combined with a reduced adjusted EBITDA loss, demonstrate disciplined capital allocation and the company's ability to secure non‑dilutive support. This reduces immediate dilution risk and extends the timeline to reach commercial scale.
Bears Say
Persistent Negative Cash FlowOperating and free cash flows remain materially negative, creating ongoing funding needs. Persistent cash burn constrains the company’s ability to invest in manufacturing scale and customer pilots, increases dependence on grants or capital raises, and heightens execution and dilution risk if revenues lag.
Small, Volatile Revenue And Deep LossesRevenue is small and volatile while fixed costs produce outsized losses and negative returns on equity. This structural top‑line weakness lengthens the path to self-sustaining operations, undermines reinvestment capacity, and makes scaling commercial deployments and proving unit economics more difficult.
Commercialisation & Partner/technical RiskKey commercialization risks persist: integration sales are deferred to 2027+, a major partner (Ionblox) arrangement was disrupted, manufacturing yields require process engineering, and full‑cell calendar life is unproven. These structural execution and partner dependencies could delay revenue and weaken margins.
Gelion PLC News
GELN FAQ
What was Gelion PLC’s price range in the past 12 months?
Gelion PLC lowest share price was 9.20 p and its highest was 30.00 p in the past 12 months.
What is Gelion PLC’s market cap?
Gelion PLC’s market cap is £30.97M.
When is Gelion PLC’s upcoming earnings report date?
Gelion PLC’s upcoming earnings report date is Nov 11, 2026 which is in 216 days.
How were Gelion PLC’s earnings last quarter?
Gelion PLC released its earnings results on Mar 02, 2026. The company reported -0.017 p earnings per share for the quarter, missing the consensus estimate of N/A by -0.017 p.
Is Gelion PLC overvalued?
According to Wall Street analysts Gelion PLC’s price is currently Overvalued.
Does Gelion PLC pay dividends?
Gelion PLC does not currently pay dividends.
What is Gelion PLC’s EPS estimate?
Gelion PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gelion PLC have?
Gelion PLC has 229,421,460 shares outstanding.
What happened to Gelion PLC’s price movement after its last earnings report?
Gelion PLC reported an EPS of -0.017 p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8.333%.
Which hedge fund is a major shareholder of Gelion PLC?
Currently, no hedge funds are holding shares in GB:GELN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Gelion PLC
Gelion plc engages in the research and development, design, manufacture, and sale of battery systems in the United Kingdom and internationally. The company offers zinc-bromide batteries under the Endure name. Its products are used in various applications, which include industrial light towers, solar and wind farms, desalination plants, mining pumps, passenger and heavy vehicles, electric buses and trains, and irrigation systems and other agricultural applications, as well as used by commercial and industrial enterprises and grid operators. The company was incorporated in 2015 and is headquartered in Eveleigh, Australia.
Technical Analysis
Options Prices
Currently, No data available
---